[Insulinemia dynamics in thyrotoxicosis].

Area of Science:

• Endocrinology
• Metabolic Research

Background:

• Thyrotoxicosis, a condition of excess thyroid hormones, significantly impacts metabolic processes.
• The relationship between thyroid dysfunction and glucose metabolism, particularly insulin secretion, requires further elucidation.

Purpose of the Study:

• To investigate the effects of thyrotoxicosis on blood immunoreactive insulin (IRI) levels.
• To assess the pancreatic beta-cell response to hyperglycemia in thyrotoxic patients.
• To evaluate changes in insulin activity post-thyroidectomy.

Main Methods:

• Measurement of blood IRI levels in thyrotoxic patients under fasting and post-glucose load conditions.
• Comparison of IRI levels with control groups.
• Assessment of IRI levels and beta-cell response following surgical treatment (subtotal strumectomy).

Main Results:

• Thyrotoxic patients exhibit altered fasting and post-glucose load IRI levels, with an enhanced pancreatic beta-cell response to hyperglycemia.
• IRI levels decrease with disease severity but remain elevated compared to controls, indicating persistent glucose hypersensitivity.
• Post-thyroidectomy, insulin activity normalizes, yet beta-cell hypersensitivity persists, leading to prolonged hyperinsulinemia after glucose load.

Conclusions:

• Thyrotoxicosis induces significant alterations in insulin secretion and pancreatic beta-cell function.
• Persistent beta-cell hypersensitivity to glucose is a key finding, even after normalization of thyroid status.
• These findings suggest a lasting impact on glucose regulation following thyrotoxicosis.